Company expands into key market verticals in diagnostics, therapeutics, and research discovery with solutions for proteins, genomics, and diagnostic assay development services. Waltham, MA – Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations. Fortis delivered [...]

SOMERVILLE, Mass. -- Trace Matters Scientific today introduced two new technologies, SUPER Mass Spec™ and SPion Link™, both category-defining mass spectrometry technologies enabling a quantum leap in the scientific study of complex clinical samples, such as tissue and blood samples. These technologies will empower scientists by providing exceptional mass spectrometry capabilities, which were highly desired [...]

Company to commercialize and create single-cell multi-omics products Seattle, WA -- Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors. Soleus Capital, Logos Capital and Bioeconomy Capital also participated in the round, bringing Parse Biosciences’ total funding to [...]

WALTHAM, Mass. -- Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP [...]

SAN JOSE, Calif. -- Takara Bio USA, Inc. (TBUSA) today announced that the European Patent Office has reviewed and confirmed the validity of TBUSA’s granted European patent EP 3105325, entitled "Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same." TBUSA’s patent was opposed [...]

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointment of Shawn Levy, Ph.D., as Senior Vice President of Applications and Scientific Affairs. A world-renowned pioneer in genomics research, Dr. Levy brings more than 20 years of in-depth knowledge to support Element's growth and strategic plans for its first sequencing platform, AVITI™, [...]

BOSTON -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced its second commercial sale, to Massachusetts General Hospital (MGH) as part of its Early Access Program. NanoMosaic previously announced that it had placed a beta system at MGH for proteomic neurological diagnostic [...]

Genomenon announced Tuesday that it was awarded a $1.7 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health to help it organize and connect patient DNA to global genomic research in the areas of rare genetic diseases and cancer. The grant is the latest in a steady stream of company advances highlighted by the addition [...]

End-to-end solution combines cryogenic and cold chain logistics, serialization compliance and global distribution WALTHAM, Mass. -- Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe. The Patheon Commercial Packaging Services for [...]

$40 million expansion will support increased production of single-use technology for critical vaccines and biologics WALTHAM, Mass. -- Thermo Fisher Scientific is investing $40 million to expand its single-use technology (SUT) manufacturing facility in Millersburg, Pa. The expansion is part of the company’s $650 million multi-year investment, announced last year, to help ensure flexible, scalable and [...]